Results 111 to 120 of about 18,246 (251)
Smoking Cessation Strategies Targeting Specific Populations
Tuberculosis and Respiratory Diseases, 2019 Quitting smoking helps smokers maintain their health and extend their lifespan by 10 or more years. Treatment strategies for smoking cessation should be tailored to individual smokers with special needs based on their specific circumstances.
Eun Mi Chun, M.D., Ph.D.
doaj
MedComm, Volume 7, Issue 4, April 2026.This graphical abstract shows the antibacterial potential of phytochemicals from 15 spices, showcasing key compounds, their extraction methods, and mechanisms of action. It highlights membrane disruption, ROS generation, enzyme inhibition, and biofilm prevention as core antibacterial pathways.
Hettiyahandi Binodh De Silva +3 more
wiley +1 more source
Health Services Research, Volume 61, Issue 2, April 2026.ABSTRACT Objective To identify factors associated with transitioning from Military Health System (MHS) to Veterans Health Administration (VHA) care in post‐9/11 veterans. Study Setting and Design Retrospective cohort study from the Long‐Term Impact of Military‐Relevant Brain Injury Consortium Phenotype Study. Data Sources and Analytic Sample Population‐
Nikki R. Wooten +10 more
wiley +1 more source
Addiction, Volume 121, Issue 4, Page 957-969, April 2026.Abstract Background and aims Evidence for motivational interviewing for smoking cessation is weak, with limited data on long‐term abstinence rates. This trial aimed to evaluate the effect of in‐hospital motivational interviewing‐based smoking cessation counselling combined with proactive referral to community‐based follow‐up on 6‐ and 12‐month ...
Karin Pleym +8 more
wiley +1 more source
Addiction, Volume 121, Issue 4, Page 994-997, April 2026.Abstract Background and aims Smokers quitting successfully with the help of e‐cigarettes often continue vaping. It is not known whether this promotes or prevents relapse back to smoking. This study aimed to determine whether use of e‐cigarettes after successful smoking cessation affects the probability of relapse later on.
Peter Hajek +8 more
wiley +1 more source
Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
British Journal of Pharmacology, Volume 183, Issue 7, Page 1364-1389, April 2026.Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen +2 more
wiley +1 more source
The role of dentists in nicotine replacement therapy
Journal of Family Medicine and Primary Care, 2020 V Rasmina, N A Uvais
doaj +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2784-2794, April 2026.Abstract Aims Prognostic markers for microvascular complications in type 1 diabetes are needed because factors beyond hyperglycaemia contribute to this risk. The triglyceride‐glucose (TyG) index is an established marker of vascular complications in type 2 diabetes; however, its clinical significance in type 1 diabetes remains unknown.
Rosa Oh +10 more
wiley +1 more source
Nicotine replacement therapy during the acute phase of aneurysmal subarachnoid hemorrhage. [PDF]
Acta Neurochir (Wien)Ghafaji H, Sorteberg A.
europepmc +1 more source
Development of "Baby, Me, & NRT": A Behavioral Intervention to Improve the Effectiveness of Nicotine Replacement Therapy in Pregnancy. [PDF]
Nicotine Tob Res, 2023 McDaid L +8 more
europepmc +1 more source